| 0 |
CONJUNCTIVAL OPERATION |
1 |
0.2000 |
| 1 |
KERATECTOMY |
1 |
0.1667 |
| 2 |
LID MARGIN DISCHARGE |
2 |
0.0741 |
| 3 |
PROPIONIBACTERIUM TEST POSITIVE |
1 |
0.0588 |
| 4 |
TEAR BREAK UP TIME DECREASED |
1 |
0.0455 |
| 5 |
EXFOLIATION SYNDROME |
1 |
0.0385 |
| 6 |
ACUTE MYELOID LEUKAEMIA (IN REMISSION) |
1 |
0.0294 |
| 7 |
PUNCTAL PLUG INSERTION |
2 |
0.0286 |
| 8 |
EYE PROSTHESIS INSERTION |
1 |
0.0256 |
| 9 |
BLADDER ULCER |
1 |
0.0244 |
| 10 |
NEURILEMMOMA BENIGN |
1 |
0.0208 |
| 11 |
DEAFNESS PERMANENT |
4 |
0.0204 |
| 12 |
EYELASH HYPERPIGMENTATION |
1 |
0.0200 |
| 13 |
BLEPHAROCHALASIS |
1 |
0.0200 |
| 14 |
BENIGN NEOPLASM OF EYE |
1 |
0.0200 |
| 15 |
GYNAECOLOGICAL EXAMINATION ABNORMAL |
1 |
0.0192 |
| 16 |
POLYGLANDULAR AUTOIMMUNE SYNDROME TYPE II |
1 |
0.0185 |
| 17 |
PULMONARY IMAGING PROCEDURE ABNORMAL |
1 |
0.0179 |
| 18 |
KERATORHEXIS |
2 |
0.0175 |
| 19 |
HORMONE REPLACEMENT THERAPY |
1 |
0.0172 |
| 20 |
OCCUPATIONAL PROBLEM ENVIRONMENTAL |
1 |
0.0169 |
| 21 |
ARCUS LIPOIDES |
1 |
0.0159 |
| 22 |
PERIORBITAL PAIN |
12 |
0.0142 |
| 23 |
AUTOPHONY |
1 |
0.0133 |
| 24 |
MIXED DEAFNESS |
1 |
0.0127 |
| 25 |
THYROID STIMULATING IMMUNOGLOBULIN INCREASED |
1 |
0.0125 |
| 26 |
VIITH NERVE INJURY |
1 |
0.0123 |
| 27 |
POST PROCEDURAL ERYTHEMA |
1 |
0.0112 |
| 28 |
PLANTAR FASCIAL FIBROMATOSIS |
1 |
0.0112 |
| 29 |
CHIMERISM |
1 |
0.0112 |
| 30 |
EYELID THICKENING |
3 |
0.0105 |
| 31 |
OTOSCLEROSIS |
1 |
0.0100 |
| 32 |
LAGOPHTHALMOS |
4 |
0.0098 |
| 33 |
CORNEAL OPERATION |
1 |
0.0097 |
| 34 |
PALATAL ULCER |
1 |
0.0094 |
| 35 |
ADHESIOLYSIS |
1 |
0.0093 |
| 36 |
CORNEAL EROSION |
5 |
0.0093 |
| 37 |
DACRYOCANALICULITIS |
1 |
0.0085 |
| 38 |
DERMATOPHYTOSIS OF NAIL |
1 |
0.0084 |
| 39 |
FOREIGN BODY IN EYE |
8 |
0.0083 |
| 40 |
BLEPHAROPLASTY |
1 |
0.0082 |
| 41 |
ENDOCRINE OPHTHALMOPATHY |
7 |
0.0081 |
| 42 |
BURKHOLDERIA TEST POSITIVE |
1 |
0.0081 |
| 43 |
CORNEAL SCAR |
4 |
0.0080 |
| 44 |
ANTI-THYROID ANTIBODY INCREASED |
1 |
0.0079 |
| 45 |
INSTILLATION SITE DRYNESS |
1 |
0.0078 |
| 46 |
EYELID OPERATION |
2 |
0.0075 |
| 47 |
INSTILLATION SITE DISCOMFORT |
1 |
0.0075 |
| 48 |
EYE COMPLICATION ASSOCIATED WITH DEVICE |
2 |
0.0074 |
| 49 |
SUPERFICIAL INJURY OF EYE |
8 |
0.0073 |
| 50 |
COCHLEA IMPLANT |
1 |
0.0073 |
| 51 |
AUTOMATIC BLADDER |
1 |
0.0072 |
| 52 |
OCULAR RETROBULBAR HAEMORRHAGE |
1 |
0.0072 |
| 53 |
INSTILLATION SITE FOREIGN BODY SENSATION |
1 |
0.0069 |
| 54 |
EYELID PAIN |
14 |
0.0069 |
| 55 |
BASOSQUAMOUS CARCINOMA |
1 |
0.0067 |
| 56 |
CONJUNCTIVAL SCAR |
1 |
0.0066 |
| 57 |
CORNEAL ABRASION |
9 |
0.0066 |
| 58 |
ENTROPION |
1 |
0.0065 |
| 59 |
INTRAOCULAR PRESSURE FLUCTUATION |
1 |
0.0051 |
| 60 |
OCULAR ROSACEA |
1 |
0.0049 |
| 61 |
HERPES ZOSTER OPHTHALMIC |
1 |
0.0049 |
| 62 |
THROMBOPHLEBITIS SEPTIC |
1 |
0.0049 |
| 63 |
EXPOSURE TO FUNGUS |
1 |
0.0047 |
| 64 |
CORNEAL INFECTION |
1 |
0.0046 |
| 65 |
VERY LOW DENSITY LIPOPROTEIN INCREASED |
1 |
0.0045 |
| 66 |
TYPE IIA HYPERLIPIDAEMIA |
1 |
0.0043 |
| 67 |
FOREIGN BODY SENSATION IN EYES |
27 |
0.0042 |
| 68 |
LACRIMATION DECREASED |
2 |
0.0042 |
| 69 |
INSTILLATION SITE LACRIMATION |
1 |
0.0041 |
| 70 |
CORNEAL DEGENERATION |
1 |
0.0041 |
| 71 |
CORNEAL NEOVASCULARISATION |
1 |
0.0040 |
| 72 |
INTRAOCULAR LENS IMPLANT |
2 |
0.0040 |
| 73 |
BURNING FEET SYNDROME |
1 |
0.0040 |
| 74 |
RIB DEFORMITY |
1 |
0.0039 |
| 75 |
CHRONIC DISEASE |
1 |
0.0039 |
| 76 |
GLAUCOMA SURGERY |
1 |
0.0039 |
| 77 |
KERATOMILEUSIS |
1 |
0.0039 |
| 78 |
INJURY CORNEAL |
2 |
0.0038 |
| 79 |
CORNEAL TRANSPLANT |
3 |
0.0038 |
| 80 |
DEPOSIT EYE |
1 |
0.0037 |
| 81 |
CARDIAC SEPTAL HYPERTROPHY |
1 |
0.0036 |
| 82 |
CHEMICAL BURNS OF EYE |
1 |
0.0036 |
| 83 |
EPIRETINAL MEMBRANE |
1 |
0.0036 |
| 84 |
ANAEMIA OF MALIGNANT DISEASE |
1 |
0.0036 |
| 85 |
ORTHOSIS USER |
1 |
0.0036 |
| 86 |
EYE ULCER |
2 |
0.0035 |
| 87 |
MALIGNANT NEOPLASM OF EYE |
1 |
0.0035 |
| 88 |
EYE DISCHARGE |
35 |
0.0034 |
| 89 |
SPASMODIC DYSPHONIA |
1 |
0.0033 |
| 90 |
IMPAIRED FASTING GLUCOSE |
1 |
0.0033 |
| 91 |
TRICHIASIS |
1 |
0.0031 |
| 92 |
EYE INFECTION VIRAL |
1 |
0.0031 |
| 93 |
SCLERAL HYPERAEMIA |
2 |
0.0029 |
| 94 |
CONJUNCTIVITIS BACTERIAL |
1 |
0.0029 |
| 95 |
POSTERIOR CAPSULE OPACIFICATION |
1 |
0.0029 |
| 96 |
EYE OPERATION |
13 |
0.0028 |
| 97 |
HYPOGLYCAEMIA UNAWARENESS |
1 |
0.0028 |
| 98 |
DRY AGE-RELATED MACULAR DEGENERATION |
3 |
0.0027 |
| 99 |
LACRIMAL STRUCTURE INJURY |
1 |
0.0027 |
| 100 |
CERVICAL POLYP |
1 |
0.0026 |
| 101 |
EYE PAIN |
146 |
0.0026 |
| 102 |
EYE INFECTION FUNGAL |
1 |
0.0026 |
| 103 |
TRI-IODOTHYRONINE INCREASED |
1 |
0.0025 |
| 104 |
GRANULOCYTE COUNT INCREASED |
1 |
0.0025 |
| 105 |
BLOOD URIC ACID ABNORMAL |
1 |
0.0025 |
| 106 |
ACOUSTIC NEUROMA |
1 |
0.0024 |
| 107 |
NAIL OPERATION |
1 |
0.0024 |
| 108 |
CORNEAL DYSTROPHY |
1 |
0.0024 |
| 109 |
RAPID EYE MOVEMENTS SLEEP ABNORMAL |
1 |
0.0024 |
| 110 |
TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME |
1 |
0.0023 |
| 111 |
EYELID INFECTION |
1 |
0.0023 |
| 112 |
HAEMORRHOID OPERATION |
1 |
0.0022 |
| 113 |
MEIBOMIAN GLAND DYSFUNCTION |
1 |
0.0022 |
| 114 |
PUNCTATE KERATITIS |
2 |
0.0022 |
| 115 |
BODY MASS INDEX DECREASED |
1 |
0.0022 |
| 116 |
OCULAR DISCOMFORT |
24 |
0.0021 |
| 117 |
BLOOD PHOSPHORUS ABNORMAL |
1 |
0.0021 |
| 118 |
INFUSION SITE HAEMATOMA |
1 |
0.0021 |
| 119 |
TYPE V HYPERLIPIDAEMIA |
1 |
0.0021 |
| 120 |
EYE IRRITATION |
117 |
0.0020 |
| 121 |
ASTIGMATISM |
3 |
0.0020 |
| 122 |
EYE COLOUR CHANGE |
2 |
0.0020 |
| 123 |
GLARE |
1 |
0.0019 |
| 124 |
KERATOPATHY |
3 |
0.0019 |
| 125 |
GRIEF REACTION |
1 |
0.0019 |
| 126 |
NIGHT BLINDNESS |
3 |
0.0019 |
| 127 |
CORNEAL DISORDER |
4 |
0.0018 |
| 128 |
PRODUCT CLOSURE ISSUE |
1 |
0.0018 |
| 129 |
TENOSYNOVITIS STENOSANS |
1 |
0.0018 |
| 130 |
EYE INFECTION BACTERIAL |
1 |
0.0018 |
| 131 |
EUSTACHIAN TUBE DYSFUNCTION |
1 |
0.0017 |
| 132 |
CORNEAL EPITHELIUM DEFECT |
1 |
0.0017 |
| 133 |
EYE LASER SURGERY |
1 |
0.0017 |
| 134 |
ERYTHEMA OF EYELID |
9 |
0.0017 |
| 135 |
THYROID OPERATION |
1 |
0.0016 |
| 136 |
POST PROCEDURAL INFLAMMATION |
1 |
0.0016 |
| 137 |
INSTILLATION SITE PAIN |
4 |
0.0016 |
| 138 |
EXCESSIVE CERUMEN PRODUCTION |
1 |
0.0016 |
| 139 |
PHOTOPHOBIA |
30 |
0.0016 |
| 140 |
EYELID IRRITATION |
4 |
0.0016 |
| 141 |
PRODUCT CONTAMINATION PHYSICAL |
4 |
0.0016 |
| 142 |
THYROXINE FREE INCREASED |
1 |
0.0016 |
| 143 |
HYPERCHLORAEMIA |
1 |
0.0016 |
| 144 |
MUCOSAL DISCOLOURATION |
1 |
0.0016 |
| 145 |
DACRYOSTENOSIS ACQUIRED |
2 |
0.0015 |
| 146 |
CELLULITIS STAPHYLOCOCCAL |
1 |
0.0015 |
| 147 |
DEAFNESS NEUROSENSORY |
5 |
0.0015 |
| 148 |
HEAD AND NECK CANCER |
1 |
0.0015 |
| 149 |
INGROWN HAIR |
1 |
0.0014 |
| 150 |
NEOVASCULAR AGE-RELATED MACULAR DEGENERATION |
2 |
0.0014 |
| 151 |
ATYPICAL FEMUR FRACTURE |
4 |
0.0014 |
| 152 |
GLASSY EYES |
1 |
0.0014 |
| 153 |
MONOCYTE PERCENTAGE INCREASED |
1 |
0.0014 |
| 154 |
MYCOBACTERIUM ABSCESSUS INFECTION |
1 |
0.0014 |
| 155 |
PRODUCT DESIGN ISSUE |
1 |
0.0014 |
| 156 |
PROTEUS INFECTION |
1 |
0.0014 |
| 157 |
VITREOUS DETACHMENT |
3 |
0.0014 |
| 158 |
GASTRIC MUCOSAL LESION |
1 |
0.0014 |
| 159 |
TRAUMATIC FRACTURE |
1 |
0.0014 |
| 160 |
OTITIS MEDIA ACUTE |
1 |
0.0014 |
| 161 |
FIBROCYSTIC BREAST DISEASE |
1 |
0.0014 |
| 162 |
CORNEAL DEPOSITS |
1 |
0.0013 |
| 163 |
TENDON DISCOMFORT |
1 |
0.0013 |
| 164 |
OCULAR HYPERAEMIA |
62 |
0.0013 |
| 165 |
EYELID DISORDER |
3 |
0.0013 |
| 166 |
ASTHENOPIA |
7 |
0.0013 |
| 167 |
PRODUCT DROPPER ISSUE |
1 |
0.0013 |
| 168 |
EYELID FUNCTION DISORDER |
1 |
0.0013 |
| 169 |
EYE INFLAMMATION |
12 |
0.0013 |
| 170 |
REACTION TO PRESERVATIVES |
1 |
0.0012 |
| 171 |
OCULAR VASCULAR DISORDER |
1 |
0.0012 |
| 172 |
ABNORMAL SENSATION IN EYE |
5 |
0.0012 |
| 173 |
DRY EYE |
58 |
0.0012 |
| 174 |
HORDEOLUM |
5 |
0.0012 |
| 175 |
BLOOD ALBUMIN INCREASED |
1 |
0.0011 |
| 176 |
ANAEMIA OF CHRONIC DISEASE |
1 |
0.0011 |
| 177 |
LIQUID PRODUCT PHYSICAL ISSUE |
8 |
0.0011 |
| 178 |
HAEMOCHROMATOSIS |
1 |
0.0011 |
| 179 |
PERIORBITAL SWELLING |
6 |
0.0011 |
| 180 |
LACRIMATION INCREASED |
32 |
0.0011 |
| 181 |
BLOOD ALKALINE PHOSPHATASE DECREASED |
1 |
0.0011 |
| 182 |
RETINAL OEDEMA |
2 |
0.0010 |
| 183 |
PCO2 DECREASED |
1 |
0.0010 |
| 184 |
BLEPHARITIS |
4 |
0.0010 |
| 185 |
SUSPECTED PRODUCT CONTAMINATION |
1 |
0.0010 |
| 186 |
BREAST ABSCESS |
1 |
0.0010 |
| 187 |
EYELIDS PRURITUS |
3 |
0.0010 |
| 188 |
SWELLING OF EYELID |
6 |
0.0010 |
| 189 |
POST PROCEDURAL SWELLING |
1 |
0.0009 |
| 190 |
PERIRECTAL ABSCESS |
1 |
0.0009 |
| 191 |
EYE INFECTION |
10 |
0.0009 |
| 192 |
BRAIN OPERATION |
2 |
0.0009 |
| 193 |
T-CELL LYMPHOMA |
1 |
0.0009 |
| 194 |
CARBON DIOXIDE DECREASED |
1 |
0.0009 |
| 195 |
LUMBAR RADICULOPATHY |
1 |
0.0009 |
| 196 |
OPTIC NERVE INJURY |
1 |
0.0009 |
| 197 |
PRODUCT CONTAMINATION MICROBIAL |
1 |
0.0008 |
| 198 |
ESCHERICHIA TEST POSITIVE |
1 |
0.0008 |
| 199 |
PULSE ABNORMAL |
2 |
0.0008 |
| 200 |
EYELID SKIN DRYNESS |
1 |
0.0008 |
| 201 |
HYPERAESTHESIA TEETH |
1 |
0.0008 |
| 202 |
TESTICULAR SWELLING |
1 |
0.0008 |
| 203 |
FACIAL PAIN |
7 |
0.0008 |
| 204 |
MEAN CELL VOLUME INCREASED |
2 |
0.0008 |
| 205 |
INFUSION SITE IRRITATION |
1 |
0.0008 |
| 206 |
ABDOMINAL OPERATION |
1 |
0.0008 |
| 207 |
RETINAL DISORDER |
2 |
0.0008 |
| 208 |
HERPES OPHTHALMIC |
1 |
0.0008 |
| 209 |
CORNEAL OPACITY |
1 |
0.0007 |
| 210 |
MUCOUS MEMBRANE DISORDER |
1 |
0.0007 |
| 211 |
ULCERATIVE KERATITIS |
2 |
0.0007 |
| 212 |
IMMUNOGLOBULINS DECREASED |
1 |
0.0007 |
| 213 |
TRACHEOSTOMY |
1 |
0.0007 |
| 214 |
EYELID MARGIN CRUSTING |
2 |
0.0007 |
| 215 |
EYELID PTOSIS |
7 |
0.0007 |
| 216 |
DARK CIRCLES UNDER EYES |
1 |
0.0007 |
| 217 |
COCCYDYNIA |
1 |
0.0007 |
| 218 |
BLINDNESS TRANSIENT |
5 |
0.0007 |
| 219 |
EYE INJURY |
2 |
0.0007 |
| 220 |
EYE ALLERGY |
1 |
0.0006 |
| 221 |
GASTROSTOMY |
1 |
0.0006 |
| 222 |
CYSTITIS INTERSTITIAL |
1 |
0.0006 |
| 223 |
EYE SWELLING |
23 |
0.0006 |
| 224 |
EYELID OEDEMA |
7 |
0.0006 |
| 225 |
BLOOD CALCIUM ABNORMAL |
1 |
0.0006 |
| 226 |
MITRAL VALVE PROLAPSE |
1 |
0.0006 |
| 227 |
SPINAL DEFORMITY |
1 |
0.0006 |
| 228 |
BLOOD CHLORIDE INCREASED |
1 |
0.0006 |
| 229 |
TREATMENT DELAYED |
1 |
0.0006 |
| 230 |
VISION BLURRED |
79 |
0.0006 |
| 231 |
PRODUCT USE COMPLAINT |
9 |
0.0006 |
| 232 |
KYPHOSIS |
1 |
0.0006 |
| 233 |
HISTOPLASMOSIS |
1 |
0.0006 |
| 234 |
NASAL OEDEMA |
1 |
0.0006 |
| 235 |
INTRAOCULAR PRESSURE INCREASED |
7 |
0.0005 |
| 236 |
MEAN CELL HAEMOGLOBIN DECREASED |
1 |
0.0005 |
| 237 |
PRODUCT ADMINISTRATION ERROR |
11 |
0.0005 |
| 238 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
3 |
0.0005 |
| 239 |
OTOTOXICITY |
1 |
0.0005 |
| 240 |
EYE PRURITUS |
18 |
0.0005 |
| 241 |
LIVING IN RESIDENTIAL INSTITUTION |
1 |
0.0005 |
| 242 |
EYE DISORDER |
17 |
0.0005 |
| 243 |
OCULAR HYPERTENSION |
1 |
0.0005 |
| 244 |
VISUAL ACUITY REDUCED |
17 |
0.0005 |
| 245 |
HYPOGEUSIA |
1 |
0.0005 |
| 246 |
JOINT NOISE |
1 |
0.0005 |
| 247 |
MACULAR DEGENERATION |
6 |
0.0005 |
| 248 |
CONCOMITANT DISEASE AGGRAVATED |
3 |
0.0005 |
| 249 |
IMPAIRED SELF-CARE |
1 |
0.0005 |
| 250 |
RED CELL DISTRIBUTION WIDTH INCREASED |
2 |
0.0005 |
| 251 |
EAR SWELLING |
1 |
0.0005 |
| 252 |
CATARACT |
28 |
0.0005 |
| 253 |
IDIOPATHIC INTRACRANIAL HYPERTENSION |
1 |
0.0004 |
| 254 |
CHRONIC GASTRITIS |
1 |
0.0004 |
| 255 |
RETINAL DETACHMENT |
4 |
0.0004 |
| 256 |
SINUS PAIN |
1 |
0.0004 |
| 257 |
MYOPIA |
1 |
0.0004 |
| 258 |
EOSINOPHIL COUNT DECREASED |
1 |
0.0004 |
| 259 |
LACUNAR INFARCTION |
1 |
0.0004 |
| 260 |
IMPAIRED QUALITY OF LIFE |
6 |
0.0004 |
| 261 |
GLAUCOMA |
8 |
0.0004 |
| 262 |
VITREOUS FLOATERS |
4 |
0.0004 |
| 263 |
NASAL POLYPS |
2 |
0.0004 |
| 264 |
RETINAL TEAR |
1 |
0.0004 |
| 265 |
BLOOD IMMUNOGLOBULIN G DECREASED |
1 |
0.0004 |
| 266 |
STEM CELL TRANSPLANT |
1 |
0.0004 |
| 267 |
PHYSICAL DECONDITIONING |
1 |
0.0004 |
| 268 |
THERAPY PARTIAL RESPONDER |
6 |
0.0004 |
| 269 |
BLOOD POTASSIUM ABNORMAL |
1 |
0.0004 |
| 270 |
WHITE BLOOD CELL DISORDER |
1 |
0.0004 |
| 271 |
LARYNGOSPASM |
1 |
0.0004 |
| 272 |
BLOOD SODIUM INCREASED |
1 |
0.0004 |
| 273 |
MIGRAINE WITH AURA |
1 |
0.0004 |
| 274 |
SKIN WRINKLING |
1 |
0.0004 |
| 275 |
RHINALGIA |
1 |
0.0004 |
| 276 |
RED BLOOD CELL COUNT INCREASED |
1 |
0.0004 |
| 277 |
PLEURITIC PAIN |
1 |
0.0004 |
| 278 |
MACULAR OEDEMA |
2 |
0.0004 |
| 279 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
2 |
0.0004 |
| 280 |
BLINDNESS UNILATERAL |
5 |
0.0004 |
| 281 |
PRODUCT CONTAINER ISSUE |
3 |
0.0003 |
| 282 |
SKIN HYPERPIGMENTATION |
3 |
0.0003 |
| 283 |
STRABISMUS |
1 |
0.0003 |
| 284 |
CATARACT OPERATION |
2 |
0.0003 |
| 285 |
METABOLIC ENCEPHALOPATHY |
1 |
0.0003 |
| 286 |
LOSS OF EMPLOYMENT |
1 |
0.0003 |
| 287 |
KERATITIS |
1 |
0.0003 |
| 288 |
DYSAESTHESIA |
1 |
0.0003 |
| 289 |
PRE-EXISTING CONDITION IMPROVED |
2 |
0.0003 |
| 290 |
IRIDOCYCLITIS |
1 |
0.0003 |
| 291 |
PHOTOPSIA |
2 |
0.0003 |
| 292 |
NON-CARDIAC CHEST PAIN |
1 |
0.0003 |
| 293 |
PNEUMONIA VIRAL |
1 |
0.0003 |
| 294 |
ENTERITIS |
2 |
0.0003 |
| 295 |
LISTLESS |
1 |
0.0003 |
| 296 |
OTITIS MEDIA |
1 |
0.0003 |
| 297 |
HIGH DENSITY LIPOPROTEIN DECREASED |
1 |
0.0003 |
| 298 |
EYE HAEMORRHAGE |
4 |
0.0003 |
| 299 |
NEPHRITIS |
1 |
0.0003 |
| 300 |
CLOSTRIDIAL INFECTION |
1 |
0.0003 |
| 301 |
BLINDNESS |
12 |
0.0003 |
| 302 |
DIABETIC RETINOPATHY |
1 |
0.0003 |
| 303 |
EAR DISCOMFORT |
3 |
0.0003 |
| 304 |
CERVICAL VERTEBRAL FRACTURE |
1 |
0.0003 |
| 305 |
BLOOD CREATININE ABNORMAL |
1 |
0.0003 |
| 306 |
HAIR GROWTH ABNORMAL |
2 |
0.0003 |
| 307 |
DEVICE USE ISSUE |
5 |
0.0003 |
| 308 |
THROMBOPHLEBITIS |
1 |
0.0003 |
| 309 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
3 |
0.0003 |
| 310 |
MACULOPATHY |
1 |
0.0003 |
| 311 |
PRODUCT SUPPLY ISSUE |
2 |
0.0003 |
| 312 |
BONE LESION |
1 |
0.0003 |
| 313 |
CHRONIC GRAFT VERSUS HOST DISEASE |
1 |
0.0003 |
| 314 |
MONOCYTE COUNT INCREASED |
1 |
0.0003 |
| 315 |
FAECES SOFT |
2 |
0.0003 |
| 316 |
HYPERACUSIS |
1 |
0.0003 |
| 317 |
MALNUTRITION |
3 |
0.0003 |
| 318 |
THROAT CLEARING |
1 |
0.0003 |
| 319 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 320 |
PEMPHIGOID |
2 |
0.0003 |
| 321 |
OSTEOPENIA |
4 |
0.0003 |
| 322 |
FACE INJURY |
1 |
0.0003 |
| 323 |
CONJUNCTIVAL HAEMORRHAGE |
1 |
0.0003 |
| 324 |
OPTIC ISCHAEMIC NEUROPATHY |
1 |
0.0003 |
| 325 |
FOREIGN BODY |
1 |
0.0002 |
| 326 |
TRIGEMINAL NEURALGIA |
1 |
0.0002 |
| 327 |
BURSITIS |
3 |
0.0002 |
| 328 |
UPPER-AIRWAY COUGH SYNDROME |
2 |
0.0002 |
| 329 |
SUICIDAL BEHAVIOUR |
1 |
0.0002 |
| 330 |
ONYCHOMADESIS |
1 |
0.0002 |
| 331 |
BUNDLE BRANCH BLOCK LEFT |
1 |
0.0002 |
| 332 |
ABSCESS LIMB |
1 |
0.0002 |
| 333 |
PURULENT DISCHARGE |
1 |
0.0002 |
| 334 |
VISUAL IMPAIRMENT |
29 |
0.0002 |
| 335 |
DIPLOPIA |
6 |
0.0002 |
| 336 |
DIVERTICULUM INTESTINAL |
1 |
0.0002 |
| 337 |
ONYCHOMYCOSIS |
1 |
0.0002 |
| 338 |
HAEMORRHAGIC ANAEMIA |
1 |
0.0002 |
| 339 |
PHYSICAL DISABILITY |
1 |
0.0002 |
| 340 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 341 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
1 |
0.0002 |
| 342 |
ACCIDENTAL OVERDOSE |
8 |
0.0002 |
| 343 |
TINNITUS |
10 |
0.0002 |
| 344 |
BLOOD CHOLESTEROL ABNORMAL |
1 |
0.0002 |
| 345 |
CONJUNCTIVITIS |
4 |
0.0002 |
| 346 |
PRODUCT PACKAGING ISSUE |
2 |
0.0002 |
| 347 |
MEDICATION RESIDUE PRESENT |
1 |
0.0002 |
| 348 |
GASTROINTESTINAL TOXICITY |
1 |
0.0002 |
| 349 |
HUMERUS FRACTURE |
1 |
0.0002 |
| 350 |
PHARYNGEAL SWELLING |
2 |
0.0002 |
| 351 |
DISABILITY |
4 |
0.0002 |
| 352 |
EXPIRED DRUG ADMINISTERED |
1 |
0.0002 |
| 353 |
HYPERNATRAEMIA |
1 |
0.0002 |
| 354 |
HEPATIC ENZYME ABNORMAL |
1 |
0.0002 |
| 355 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 356 |
TASTE DISORDER |
4 |
0.0002 |
| 357 |
DYSLIPIDAEMIA |
1 |
0.0002 |
| 358 |
CEREBRAL ISCHAEMIA |
1 |
0.0002 |
| 359 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 360 |
TENDERNESS |
2 |
0.0002 |
| 361 |
TRANSFUSION |
2 |
0.0002 |
| 362 |
POOR QUALITY PRODUCT ADMINISTERED |
2 |
0.0002 |
| 363 |
SCRATCH |
2 |
0.0002 |
| 364 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 365 |
PRODUCT RESIDUE PRESENT |
1 |
0.0002 |
| 366 |
BRUXISM |
1 |
0.0002 |
| 367 |
GINGIVITIS |
1 |
0.0002 |
| 368 |
BIPOLAR DISORDER |
2 |
0.0002 |
| 369 |
TIC |
1 |
0.0002 |
| 370 |
JAW DISORDER |
1 |
0.0002 |
| 371 |
HYPERKERATOSIS |
1 |
0.0002 |
| 372 |
SKIN INFECTION |
2 |
0.0002 |
| 373 |
STATUS EPILEPTICUS |
2 |
0.0002 |
| 374 |
HEAD DISCOMFORT |
3 |
0.0002 |
| 375 |
BLOOD PRESSURE INADEQUATELY CONTROLLED |
1 |
0.0002 |
| 376 |
SQUAMOUS CELL CARCINOMA OF SKIN |
1 |
0.0002 |
| 377 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
6 |
0.0002 |
| 378 |
DISCOMFORT |
10 |
0.0002 |
| 379 |
PHARYNGITIS |
2 |
0.0002 |
| 380 |
NASAL DRYNESS |
1 |
0.0002 |
| 381 |
ROTATOR CUFF SYNDROME |
2 |
0.0002 |
| 382 |
PROCTALGIA |
1 |
0.0002 |
| 383 |
EAR PAIN |
3 |
0.0002 |
| 384 |
INCORRECT PRODUCT STORAGE |
2 |
0.0002 |
| 385 |
EXPIRED PRODUCT ADMINISTERED |
5 |
0.0002 |
| 386 |
EXTRASYSTOLES |
1 |
0.0001 |
| 387 |
THERMAL BURN |
1 |
0.0001 |
| 388 |
DIVERTICULUM |
1 |
0.0001 |
| 389 |
RETINAL HAEMORRHAGE |
1 |
0.0001 |
| 390 |
RED BLOOD CELL COUNT DECREASED |
4 |
0.0001 |
| 391 |
RASH PUSTULAR |
1 |
0.0001 |
| 392 |
SURGERY |
8 |
0.0001 |
| 393 |
ORAL DISORDER |
1 |
0.0001 |
| 394 |
NASAL CONGESTION |
8 |
0.0001 |
| 395 |
PSYCHIATRIC SYMPTOM |
1 |
0.0001 |
| 396 |
IMMUNODEFICIENCY |
2 |
0.0001 |
| 397 |
SNEEZING |
3 |
0.0001 |
| 398 |
HYPOAESTHESIA ORAL |
2 |
0.0001 |
| 399 |
ECONOMIC PROBLEM |
2 |
0.0001 |
| 400 |
DRUG DISPENSING ERROR |
2 |
0.0001 |
| 401 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 402 |
DEVICE PHYSICAL PROPERTY ISSUE |
1 |
0.0001 |
| 403 |
LOW DENSITY LIPOPROTEIN INCREASED |
1 |
0.0001 |
| 404 |
HIP FRACTURE |
4 |
0.0001 |
| 405 |
MUSCLE DISORDER |
1 |
0.0001 |
| 406 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
25 |
0.0001 |
| 407 |
BLOOD POTASSIUM INCREASED |
2 |
0.0001 |
| 408 |
ABNORMAL FAECES |
1 |
0.0001 |
| 409 |
HICCUPS |
1 |
0.0001 |
| 410 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
3 |
0.0001 |
| 411 |
BLOOD UREA INCREASED |
2 |
0.0001 |
| 412 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
2 |
0.0001 |
| 413 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 414 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 415 |
MUSCLE STRAIN |
1 |
0.0001 |
| 416 |
SKIN SWELLING |
1 |
0.0001 |
| 417 |
ORTHOSTATIC HYPOTENSION |
2 |
0.0001 |
| 418 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 419 |
BLOOD CALCIUM INCREASED |
1 |
0.0001 |
| 420 |
SPINAL OSTEOARTHRITIS |
1 |
0.0001 |
| 421 |
GRIP STRENGTH DECREASED |
1 |
0.0001 |
| 422 |
IMMUNOSUPPRESSION |
1 |
0.0001 |
| 423 |
BLOOD BILIRUBIN INCREASED |
3 |
0.0001 |
| 424 |
HIDRADENITIS |
1 |
0.0001 |
| 425 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 426 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 427 |
BACTERIAL INFECTION |
2 |
0.0001 |
| 428 |
LEUKAEMIA |
1 |
0.0001 |
| 429 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 430 |
INFLAMMATORY BOWEL DISEASE |
1 |
0.0001 |
| 431 |
HOSPICE CARE |
1 |
0.0001 |
| 432 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 433 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
2 |
0.0001 |
| 434 |
HAEMATOCRIT DECREASED |
2 |
0.0001 |
| 435 |
BRAIN INJURY |
1 |
0.0001 |
| 436 |
PRODUCT DOSE OMISSION ISSUE |
29 |
0.0001 |
| 437 |
DRY THROAT |
1 |
0.0001 |
| 438 |
SLUGGISHNESS |
1 |
0.0001 |
| 439 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 440 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 441 |
FEMUR FRACTURE |
3 |
0.0001 |
| 442 |
PETECHIAE |
1 |
0.0001 |
| 443 |
KNEE ARTHROPLASTY |
2 |
0.0001 |
| 444 |
LIVER FUNCTION TEST INCREASED |
2 |
0.0001 |
| 445 |
HYPOACUSIS |
4 |
0.0001 |
| 446 |
SKIN CANCER |
2 |
0.0001 |
| 447 |
RHINORRHOEA |
6 |
0.0001 |
| 448 |
SKIN LACERATION |
1 |
0.0001 |
| 449 |
PULMONARY THROMBOSIS |
1 |
0.0001 |
| 450 |
DENTAL CARIES |
1 |
0.0001 |
| 451 |
FISTULA |
1 |
0.0001 |
| 452 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 453 |
PRODUCT AVAILABILITY ISSUE |
2 |
0.0001 |
| 454 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 455 |
MYOCARDITIS |
1 |
0.0001 |
| 456 |
DRY MOUTH |
7 |
0.0001 |
| 457 |
MADAROSIS |
1 |
0.0001 |
| 458 |
VASCULITIS |
1 |
0.0001 |
| 459 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
6 |
0.0001 |
| 460 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 461 |
BACTERAEMIA |
1 |
0.0001 |
| 462 |
WRIST FRACTURE |
1 |
0.0001 |
| 463 |
HYPERGLYCAEMIA |
3 |
0.0001 |
| 464 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 465 |
CYST |
1 |
0.0001 |
| 466 |
PRODUCT STORAGE ERROR |
7 |
0.0001 |
| 467 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 468 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
2 |
0.0001 |
| 469 |
SKIN ULCER |
2 |
0.0001 |
| 470 |
INJECTION SITE INDURATION |
1 |
0.0001 |
| 471 |
SWELLING FACE |
5 |
0.0001 |
| 472 |
DEAFNESS |
2 |
0.0001 |
| 473 |
BEDRIDDEN |
1 |
0.0001 |
| 474 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 475 |
DERMATITIS ATOPIC |
4 |
0.0001 |
| 476 |
TOOTH INFECTION |
1 |
0.0001 |
| 477 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 478 |
DEPRESSED MOOD |
4 |
0.0001 |
| 479 |
ADVERSE REACTION |
1 |
0.0001 |
| 480 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 481 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
| 482 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 483 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 484 |
MASS |
1 |
0.0001 |
| 485 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 486 |
MUSCULAR WEAKNESS |
8 |
0.0001 |
| 487 |
ANOSMIA |
1 |
0.0001 |
| 488 |
FLUID OVERLOAD |
1 |
0.0001 |
| 489 |
DYSPHONIA |
4 |
0.0001 |
| 490 |
BONE PAIN |
4 |
0.0001 |
| 491 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 492 |
PULMONARY MASS |
1 |
0.0001 |
| 493 |
BLOOD POTASSIUM DECREASED |
2 |
0.0001 |
| 494 |
PRODUCT QUALITY ISSUE |
9 |
0.0001 |
| 495 |
THERAPEUTIC RESPONSE DECREASED |
4 |
0.0001 |
| 496 |
INSURANCE ISSUE |
1 |
0.0001 |
| 497 |
DRUG ADMINISTRATION ERROR |
2 |
0.0001 |
| 498 |
THYROID DISORDER |
1 |
0.0001 |
| 499 |
LYMPHOMA |
1 |
0.0001 |
| 500 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 501 |
ANKLE FRACTURE |
1 |
0.0001 |
| 502 |
LUNG INFECTION |
1 |
0.0001 |
| 503 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 504 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
| 505 |
BRAIN FOG |
1 |
0.0001 |
| 506 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 507 |
MIGRAINE |
6 |
0.0001 |
| 508 |
OBESITY |
1 |
0.0001 |
| 509 |
SCIATICA |
1 |
0.0001 |
| 510 |
HYPOTHYROIDISM |
2 |
0.0001 |
| 511 |
GASTROOESOPHAGEAL REFLUX DISEASE |
5 |
0.0001 |
| 512 |
BACK DISORDER |
1 |
0.0001 |
| 513 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 514 |
PSYCHOMOTOR HYPERACTIVITY |
1 |
0.0001 |
| 515 |
LIP SWELLING |
2 |
0.0001 |
| 516 |
SKIN DISORDER |
2 |
0.0001 |
| 517 |
CELLULITIS |
3 |
0.0001 |
| 518 |
CANDIDA INFECTION |
1 |
0.0001 |
| 519 |
SCAR |
1 |
0.0001 |
| 520 |
EMOTIONAL DISTRESS |
7 |
0.0001 |
| 521 |
RASH MACULAR |
2 |
0.0001 |
| 522 |
HEART RATE DECREASED |
2 |
0.0001 |
| 523 |
HYPOXIA |
2 |
0.0001 |
| 524 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 525 |
LYMPHOCYTE COUNT DECREASED |
1 |
0.0001 |
| 526 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 527 |
THERAPY INTERRUPTED |
4 |
0.0001 |
| 528 |
THIRST |
1 |
0.0001 |
| 529 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 530 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 531 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 532 |
UNDERDOSE |
4 |
0.0001 |
| 533 |
BLOOD GLUCOSE ABNORMAL |
1 |
0.0001 |
| 534 |
BRONCHITIS |
4 |
0.0001 |
| 535 |
HYPERSENSITIVITY |
10 |
0.0001 |
| 536 |
NECK PAIN |
3 |
0.0001 |
| 537 |
ERYTHEMA |
11 |
0.0001 |
| 538 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 539 |
INCORRECT DOSE ADMINISTERED |
12 |
0.0001 |
| 540 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 541 |
FEELING JITTERY |
1 |
0.0001 |
| 542 |
DRUG PRESCRIBING ERROR |
1 |
0.0001 |
| 543 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 544 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 545 |
HAEMORRHOIDS |
1 |
0.0001 |
| 546 |
CHOKING |
1 |
0.0001 |
| 547 |
HEADACHE |
32 |
0.0001 |
| 548 |
ARTHRITIS |
4 |
0.0001 |
| 549 |
WHEEZING |
3 |
0.0001 |
| 550 |
SINUS DISORDER |
1 |
0.0001 |
| 551 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 552 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
9 |
0.0000 |
| 553 |
MUSCLE SPASMS |
9 |
0.0000 |
| 554 |
INSOMNIA |
13 |
0.0000 |
| 555 |
HAEMOGLOBIN DECREASED |
5 |
0.0000 |
| 556 |
OSTEOPOROSIS |
2 |
0.0000 |
| 557 |
INJECTION SITE WARMTH |
1 |
0.0000 |
| 558 |
RIB FRACTURE |
1 |
0.0000 |
| 559 |
POLLAKIURIA |
2 |
0.0000 |
| 560 |
SKIN EXFOLIATION |
4 |
0.0000 |
| 561 |
OSTEOARTHRITIS |
2 |
0.0000 |
| 562 |
GAIT DISTURBANCE |
9 |
0.0000 |
| 563 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 564 |
HYPOAESTHESIA |
7 |
0.0000 |
| 565 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 566 |
BALANCE DISORDER |
4 |
0.0000 |
| 567 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 568 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 569 |
ACUTE KIDNEY INJURY |
7 |
0.0000 |
| 570 |
INTENTIONAL PRODUCT MISUSE |
4 |
0.0000 |
| 571 |
MUSCULOSKELETAL STIFFNESS |
4 |
0.0000 |
| 572 |
GASTROINTESTINAL DISORDER |
4 |
0.0000 |
| 573 |
RASH PAPULAR |
1 |
0.0000 |
| 574 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 575 |
PARAESTHESIA |
7 |
0.0000 |
| 576 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 577 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 578 |
OROPHARYNGEAL PAIN |
4 |
0.0000 |
| 579 |
DECREASED APPETITE |
10 |
0.0000 |
| 580 |
RENAL DISORDER |
2 |
0.0000 |
| 581 |
COUGH |
12 |
0.0000 |
| 582 |
BURNING SENSATION |
3 |
0.0000 |
| 583 |
INJURY |
3 |
0.0000 |
| 584 |
PRODUCT USE ISSUE |
8 |
0.0000 |
| 585 |
FATIGUE |
33 |
0.0000 |
| 586 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
3 |
0.0000 |
| 587 |
FALL |
14 |
0.0000 |
| 588 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 589 |
MULTIPLE SCLEROSIS |
2 |
0.0000 |
| 590 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 591 |
RESPIRATORY FAILURE |
3 |
0.0000 |
| 592 |
FIBROMYALGIA |
1 |
0.0000 |
| 593 |
DRUG INEFFECTIVE |
54 |
0.0000 |
| 594 |
DYSGEUSIA |
3 |
0.0000 |
| 595 |
AGEUSIA |
1 |
0.0000 |
| 596 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 597 |
HOT FLUSH |
3 |
0.0000 |
| 598 |
WEIGHT DECREASED |
11 |
0.0000 |
| 599 |
BACK PAIN |
9 |
0.0000 |
| 600 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 601 |
NERVOUSNESS |
2 |
0.0000 |
| 602 |
JOINT STIFFNESS |
1 |
0.0000 |
| 603 |
HYPERTENSION |
8 |
0.0000 |
| 604 |
EAR INFECTION |
1 |
0.0000 |
| 605 |
PLATELET COUNT DECREASED |
4 |
0.0000 |
| 606 |
PAIN IN EXTREMITY |
11 |
0.0000 |
| 607 |
FEAR |
1 |
0.0000 |
| 608 |
OFF LABEL USE |
32 |
0.0000 |
| 609 |
DIVERTICULITIS |
1 |
0.0000 |
| 610 |
ARTHROPATHY |
2 |
0.0000 |
| 611 |
FEELING COLD |
1 |
0.0000 |
| 612 |
DEMENTIA |
1 |
0.0000 |
| 613 |
WOUND |
1 |
0.0000 |
| 614 |
ALOPECIA |
7 |
0.0000 |
| 615 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 616 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 617 |
MYALGIA |
6 |
0.0000 |
| 618 |
URINARY TRACT INFECTION |
6 |
0.0000 |
| 619 |
DEPRESSION |
8 |
0.0000 |
| 620 |
ANXIETY |
10 |
0.0000 |
| 621 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 622 |
HERPES ZOSTER |
2 |
0.0000 |
| 623 |
NEEDLE ISSUE |
1 |
0.0000 |
| 624 |
DYSSTASIA |
1 |
0.0000 |
| 625 |
INTENTIONAL PRODUCT USE ISSUE |
3 |
0.0000 |
| 626 |
DISEASE PROGRESSION |
4 |
0.0000 |
| 627 |
DYSPNOEA |
19 |
0.0000 |
| 628 |
IRRITABILITY |
2 |
0.0000 |
| 629 |
SWELLING |
3 |
0.0000 |
| 630 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 631 |
HEAD INJURY |
1 |
0.0000 |
| 632 |
CYSTITIS |
1 |
0.0000 |
| 633 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 634 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 635 |
ATRIAL FIBRILLATION |
3 |
0.0000 |
| 636 |
IMPAIRED HEALING |
1 |
0.0000 |
| 637 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 638 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 639 |
FUNGAL INFECTION |
1 |
0.0000 |
| 640 |
SYNCOPE |
3 |
0.0000 |
| 641 |
DRY SKIN |
4 |
0.0000 |
| 642 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 643 |
GAIT INABILITY |
1 |
0.0000 |
| 644 |
CEREBROVASCULAR ACCIDENT |
5 |
0.0000 |
| 645 |
SINUSITIS |
3 |
0.0000 |
| 646 |
ILLNESS |
3 |
0.0000 |
| 647 |
NAUSEA |
23 |
0.0000 |
| 648 |
COVID-19 |
5 |
0.0000 |
| 649 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 650 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 651 |
CONSTIPATION |
6 |
0.0000 |
| 652 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 653 |
RESTLESSNESS |
1 |
0.0000 |
| 654 |
DYSURIA |
1 |
0.0000 |
| 655 |
INFLUENZA |
3 |
0.0000 |
| 656 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 657 |
EPISTAXIS |
2 |
0.0000 |
| 658 |
BLOOD GLUCOSE INCREASED |
5 |
0.0000 |
| 659 |
ARTHRALGIA |
11 |
0.0000 |
| 660 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 661 |
COLITIS |
1 |
0.0000 |
| 662 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 663 |
DIABETES MELLITUS |
2 |
0.0000 |
| 664 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 665 |
DIZZINESS |
13 |
0.0000 |
| 666 |
PRURITUS |
10 |
0.0000 |
| 667 |
PERIPHERAL SWELLING |
4 |
0.0000 |
| 668 |
PALPITATIONS |
3 |
0.0000 |
| 669 |
PAIN |
15 |
0.0000 |
| 670 |
DRUG DOSE OMISSION |
4 |
0.0000 |
| 671 |
ASTHENIA |
9 |
0.0000 |
| 672 |
TOXICITY TO VARIOUS AGENTS |
4 |
0.0000 |
| 673 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 674 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 675 |
SEPTIC SHOCK |
1 |
0.0000 |
| 676 |
MENTAL DISORDER |
1 |
0.0000 |
| 677 |
ANGIOEDEMA |
1 |
0.0000 |
| 678 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 679 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 680 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 681 |
SKIN IRRITATION |
1 |
0.0000 |
| 682 |
ADVERSE EVENT |
2 |
0.0000 |
| 683 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 684 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 685 |
CARDIAC DISORDER |
2 |
0.0000 |
| 686 |
NEUROPATHY PERIPHERAL |
2 |
0.0000 |
| 687 |
ANAEMIA |
4 |
0.0000 |
| 688 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 689 |
MALAISE |
9 |
0.0000 |
| 690 |
DYSPEPSIA |
2 |
0.0000 |
| 691 |
HEART RATE INCREASED |
2 |
0.0000 |
| 692 |
PRODUCT USE IN UNAPPROVED INDICATION |
5 |
0.0000 |
| 693 |
HYPOTENSION |
4 |
0.0000 |
| 694 |
FLUID RETENTION |
1 |
0.0000 |
| 695 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 696 |
HOSPITALISATION |
3 |
0.0000 |
| 697 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
0.0000 |
| 698 |
INFLAMMATION |
1 |
0.0000 |
| 699 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 700 |
ECZEMA |
1 |
0.0000 |
| 701 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 702 |
SPEECH DISORDER |
1 |
0.0000 |
| 703 |
PANCREATITIS |
1 |
0.0000 |
| 704 |
DRUG INTERACTION |
3 |
0.0000 |
| 705 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 706 |
DIARRHOEA |
12 |
0.0000 |
| 707 |
PNEUMONIA |
6 |
0.0000 |
| 708 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 709 |
RASH |
8 |
0.0000 |
| 710 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 711 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 712 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 713 |
MEDICATION ERROR |
1 |
0.0000 |
| 714 |
SEPSIS |
2 |
0.0000 |
| 715 |
PANCYTOPENIA |
1 |
0.0000 |
| 716 |
BLISTER |
1 |
0.0000 |
| 717 |
HYPONATRAEMIA |
1 |
0.0000 |
| 718 |
SEIZURE |
2 |
0.0000 |
| 719 |
MYOCARDIAL INFARCTION |
3 |
0.0000 |
| 720 |
FEELING ABNORMAL |
4 |
0.0000 |
| 721 |
STOMATITIS |
1 |
0.0000 |
| 722 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 723 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 724 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 725 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 726 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 727 |
AMNESIA |
1 |
0.0000 |
| 728 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 729 |
DEVICE DIFFICULT TO USE |
1 |
0.0000 |
| 730 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 731 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 732 |
DEHYDRATION |
2 |
0.0000 |
| 733 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 734 |
NEUTROPENIA |
2 |
0.0000 |
| 735 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 736 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 737 |
PYREXIA |
5 |
0.0000 |
| 738 |
SLEEP DISORDER |
1 |
0.0000 |
| 739 |
MOBILITY DECREASED |
1 |
0.0000 |
| 740 |
WEIGHT INCREASED |
3 |
0.0000 |
| 741 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 742 |
DRUG DEPENDENCE |
2 |
0.0000 |
| 743 |
THROMBOSIS |
1 |
0.0000 |
| 744 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 745 |
TREATMENT FAILURE |
1 |
0.0000 |
| 746 |
TREMOR |
2 |
0.0000 |
| 747 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 748 |
URTICARIA |
2 |
0.0000 |
| 749 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 750 |
DEVICE ISSUE |
1 |
0.0000 |
| 751 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 752 |
CHEST PAIN |
2 |
0.0000 |
| 753 |
BREAST CANCER |
1 |
0.0000 |
| 754 |
DYSPHAGIA |
1 |
0.0000 |
| 755 |
CONTUSION |
1 |
0.0000 |
| 756 |
SOMNOLENCE |
2 |
0.0000 |
| 757 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 758 |
ASTHMA |
1 |
0.0000 |
| 759 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 760 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 761 |
JOINT SWELLING |
1 |
0.0000 |
| 762 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 763 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 764 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 765 |
RENAL FAILURE |
1 |
0.0000 |
| 766 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 767 |
INFECTION |
1 |
0.0000 |
| 768 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 769 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 770 |
VOMITING |
3 |
0.0000 |
| 771 |
DEATH |
4 |
0.0000 |
| 772 |
OVERDOSE |
1 |
0.0000 |
| 773 |
ABDOMINAL PAIN |
1 |
0.0000 |